Effectiveness of measures to prevent needlestick injuries among ...

More documents

Recommendations

Info

8 Bibliography [12] Verordnung über Sicherheit und Gesundheitsschutz bei Tätigkeiten mit biologischen Arbeitsstoffen vom 27. Januar 1999 (BGBl. I S. 50), zul. geänd. durch Artikel 8 der Verordnung vom 29. Dezember 2004 (BGBl. I S.3807-3812) [13] Gesetz über die Durchführung von Maßnahmen des Arbeitsschutzes zur Verbesserung der Sicherheit und des Gesundheitsschutzes der Beschäftigten bei der Arbeit (Arbeitsschutzgesetz – ArbSchG) vom 7. August 1996. BGBl. I (1996), S. 1246, zul. geänd. durch Art. 11 Nr. 20 G v. 30.07.2004 BGBl. I, S. 1950 [14] Technische Regeln für Biologische Arbeitsstoffe: Biologische Arbeitsstoffe im Gesundheitswesen und in der Wohlfahrtspflege (TRBA 250). BArbBl. (2003) no.11, p. 53-73 [15] Waclawski, E. R.: Evaluation of potential reduction in blood and body fluid exposures by use of alternative instruments. Occup. Med. 54 (2004) no. 8, p. 567- 569 [16] National Library of Medicine (NLM): PubMed: Retrieval on the World Wide Web. http://www.nlm.nih.gov/pubs/factsheets. November 1, 2004 [17] Perry, J.: CDC releases national needlestick estimates. Exposure Preval. 5 (2000) no. 2, p. 19 [18] Porta, C.; Handelman, E.; McGovern, P.: Needlestick injuries among health care workers. A literature review. AAOHN J. 47 (1999) no. 6, p. 237-244 [19] Lee, J. M.; Botteman, M. F.; Xanthakos, N.; Nicklasson, L.: Needlestick injuries in the United States. Epidemiologic, economic, and quality of life issues. AAOHN J. 53 (2005) no. 3, p. 117-133 [20] Hofmann, F.; Kralj, N.; Beie, M.: Kanülenstichverletzungen im Gesundheitsdienst − Häufigkeit, Ursachen und Präventionsstrategien [Needle stick injuries in health care − frequency, causes und preventive strategies]. Gesundheitswesen 64 (2002) no. 5, p. 259-266 [21] Lewis, F. R.; Short, L. J.; Howard, R. J.; Jacobs, A. J.; Roche, N. E.: Epidemiology of injuries by needles and other sharp instruments. Minimizing sharp injuries in Report „Needlestick injuries“ 76
8 Bibliography gynecologic and obstetric operations. Surg. Clin. North Am. 75 (1995) no. 6, p. 1105-1121 [22] GAO (General Accounting Office): Occupational safety: Selected cost and benefit implications of needlestick prevention devices for hospitals. GAO-01-60R. 17 November 2000 [23] CDC: Workbook for designing, implementing and evaluating a sharps injury prevention program. http://www.cdc.gov/sharpssafety/index.html (April 2005) [24] Haiduven, D. J.; Simpkins, S. M.; Phillips, E. S.; Stevens, D. A.: A survey of percutaneous/mucocutaneous injury reporting in a public teaching hospital. J. Hosp. Infect. 41 (1999) no. 2, p. 151-154 [25] Luthi, J. C.; Dubois-Arber, F.; Iten, A.; Maziero, A.; Colombo, C.; Jost, J.; Francioli, P.: The occurrence of percutaneous injuries to health care workers: a cross sectional survey in seven Swiss hospitals. Schweiz. Med. Wochenschr. 128 (1998) no. 14, p. 536-543 [26] Lymer, U. B.; Schutz, A. A.; Isaksson, B.: A descriptive study of blood exposure incidents among healthcare workers in a university hospital in Sweden. J. Hosp. Infect. 35 (1997) no. 3, p. 223-235 [27] O'Neill, T. M.; Abbott, A. V.; Radecki, S. E.: Risk of needlesticks and occupational exposures among residents and medical students. Arch. Intern. Med. 152 (1992) no. 7, p. 1451-1456 [28] Pournaras, S.; Tsakris, A.; Mandraveli, K.; Faitatzidou, A.; Douboyas, J.; Tourkantonis, A.: Reported needlestick and sharp injuries among health care workers in a Greek general hospital. Occup. Med. (London) 49 (1999) no. 7, p. 423-426 [29] Risks to users. Ed.: European Medical Association (EMA), November 2004. http://www.emanet.org/safety/1-11_risks_usr.html [30] Pedersen, E. B.: Potentielt smittefarlig blodeksposition blandt sygehuspersonale. En retrospektiv undersogelse af systematisk registrerede ekspositioner i perioden 1990-1994 [Potentially hazardous exposure to blood among hospital personnel. Report „Needlestick injuries“ 77
Page 1:
Effectiveness of measures to preven
Page 4 and 5:
Authors: Sandra I. Sulsky, Thomas B
Page 6 and 7:
Wirksamkeit und Wirtschaftlichkeit
Page 8 and 9:
Eficacia y rentabilidad de medidas
Page 10 and 11:
5 Cost effectiveness ..............
Page 13 and 14:
Preface Preface It has long been re
Page 15 and 16:
1 Introduction 1 Introduction Altho
Page 17 and 18:
1 Introduction scientific laborator
Page 19:
1 Introduction To complete each of
Page 23 and 24:
3 Descriptive epidemiology of NSI 3
Page 25 and 26:
3 Descriptive epidemiology of NSI a
Page 27 and 28: 3 Descriptive epidemiology of NSI c
Page 29 and 30: 3 Descriptive epidemiology of NSI s
Page 31 and 32: 3 Descriptive epidemiology of NSI h
Page 33 and 34: 4 Intervention program evaluation 4
Page 35 and 36: 4 Intervention program evaluation u
Page 37 and 38: 4 Intervention program evaluation d
Page 39 and 40: 4 Intervention program evaluation (
Page 41 and 42: 4 Intervention program evaluation c
Page 43 and 44: 4 Intervention program evaluation t
Page 45 and 46: 4 Intervention program evaluation a
Page 47 and 48: 4 Intervention program evaluation d
Page 53 and 54: 4 Intervention program evaluation b
Page 55 and 56: 4 Intervention program evaluation 4
Page 57 and 58: 4 Intervention program evaluation C
Page 59: 4 Intervention program evaluation a
Page 62 and 63: 5 Cost effectiveness Both costs and
Page 64 and 65: 5 Cost effectiveness 21 % by using
Page 66 and 67: 5 Cost effectiveness the high HBV v
Page 68 and 69: 5 Cost effectiveness After the impl
Page 70 and 71: 5 Cost effectiveness estimating cos
Page 73 and 74: 6 Discussion 6 Discussion This repo
Page 75: 7 Recommendations 7 Recommendations
Page 80 and 81: 8 Bibliography A retrospective stud
Page 82 and 83: 8 Bibliography [48] Gartner, K.: Im
Page 84 and 85: 8 Bibliography [66] O'Connor, R. E.
Page 86 and 87: 8 Bibliography [86] Thomas, S.; Aga
Page 89 and 90: Tables Table 1: Overview of prevent
Page 91 and 92: Tables Table 3: Distribution of cou
Page 93 and 94: Tables Table 5: Distribution of nee
Page 95 and 96: Tables Table 7: Activity during nee
Page 97 and 98: Tables Table 9: Screening Criteria
Page 99 and 100: Tables Table 11: Quality indicators
Page 101 and 102: Tables Table 13: Examples of estima
Page 103 and 104: Annex 1: Glossary and abbreviations
Page 105 and 106: Annex 1: Glossary and abbreviations
Page 107 and 108: Annex 2: QBCR review form COMPARISO
Page 109 and 110: Annex 2: QBCR review form Character
Page 111 and 112: Annex 2: QBCR review form DISCUSSIO
Page 113 and 114: Annex 3: Definitions/guidelines for
Page 115 and 116: Annex 3: Definitions/guidelines for
Page 117 and 118: Annex 4: Working group Needlestick
show all

Effectiveness of measures to prevent needlestick injuries among ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?